Clinical Trials Browser

Phase 2 × Tablets × 1 year × Clear all

NCT04802590 2026-03-04

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

Phase 2 Active not recruiting

Lymphoma, Mantle-Cell

NCT07217938 2026-03-03

TRADstat

Phase 2 Recruiting

Deglutition Disorders, Head and Neck Neoplasms

NCT07292207 2025-12-18

ARCHE

Phase 2 Not yet recruiting

Breast Neoplasms

NCT05559164 2025-11-14

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Phase 2 Recruiting

Breast Neoplasms, Cardiotoxicity

NCT05392608 2025-09-17

SEQUEL-Breast

Phase 2 Active not recruiting

Breast Neoplasms, Genetic Diseases, Inborn

NCT06033092 2025-08-28

TOLERANT

Phase 2 Active not recruiting

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT06150898 2025-06-13

KePreSt

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

NCT05247268 2025-04-06

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

Phase 2 Recruiting

Endometrial Neoplasms

NCT02852486 2025-03-30

EDI-PIO

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive